ReviewFrontiers in immunology2025

Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy.

Xuebing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.